Author of the publication

Examining the In Vitro Efficacy of the IAP Antagonist Birinapant as a Single Agent or in Combination With Dacarbazine to Induce Melanoma Cell Death

, , , , , and . Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 25 (9): 1489--1494 (November 2017)
DOI: 10.3727/096504017x14897145996933

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Combined logical and data-driven models for linking signalling pathways to cellular response., , , , and . BMC Systems Biology, (2011)Protein Kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines, , , , , , , , , and . iScience, (2024)TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma, , , , , , , , and . Cell Death & Differentiation, (March 2019)Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma, , , , and . BMC Cell Biology, 19 (1): 28 (December 2019)Post-treatment de-phosphorylation of p53 correlates with dasatinib responsiveness in malignant melanoma, , , , and . BMC Cell Biology, (2018)Detecting and Removing Inconsistencies between Experimental Data and Signaling Network Topologies Using Integer Linear Programming on Interaction Graphs., , , and . PLoS Computational Biology, (2013)Modeling pro-death signaling pathways in cancer hepatocytes using multi-combinatorial treatments of inhibitors and stimuli., , and . BIBE, page 1-5. IEEE, (2008)Protein kinase D drives the secretion of invasion mediators in triple-negative breast cancer cell lines, , , , , , , , , and . iScience, 27 (2): 108958 (2024)The Logic of EGFR/ErbB Signaling: Theoretical Properties and Analysis of High-Throughput Data., , , , and . PLoS Computational Biology, (2009)Identifying Drug Effects via Pathway Alterations using an Integer Linear Programming Optimization Formulation on Phosphoproteomic Data., , , , , and . PLoS Computational Biology, (2009)